SEGMENT REPORTING

6 Months Ended

Jun. 30, 2023

Segment Reporting [Abstract]

SEGMENT REPORTING

NOTE 11 - SEGMENT REPORTING

FASB Codification Topic 280, Segment Reporting, establishes standards for reporting financial and descriptive information about an enterprise’s reportable segments. The Company has two reportable segments: the design, manufacture, assembly and distribution of disinfecting systems for use in healthcare, hospitality, and commercial municipal and residential markets (disinfectant segment) and the manufacture of fine mirrors specifically for the hospitality industry (hospitality segment). The segments are determined based on several factors, including the nature of products and services, the nature of production processes, customer base, delivery channels and similar economic characteristics.

An operating segment’s performance is evaluated based on its pre-tax operating contribution, or segment income. Segment income is defined as net sales less cost of sales, segment selling, general and administrative expenses, research and development costs and stock-based compensation. It does not include other charges (income), net and interest and other, net.

	Hospitality		Disinfectant/ Healthy Building Technologies		Corporate		Total
Balance sheet at June 30, 2023
Assets	$	11,009,842	$	58,173,405	$	3,788,809	$	72,972,056
Liabilities	$	9,312,841	$	29,166,709	$	9,521,558	$	48,001,108
Balance sheet at December 31, 2022
Assets	$	9,638,828	$	19,831,097	$	3,257,502	$	32,727,427
Liabilities	$	10,666,643	$	1,545,217	$	3,281,672	$	15,493,532

	Hospitality		Disinfectant/ Healthy Building Technologies		Corporate		Total
Income Statement for the three months ended June 30, 2023:
Net Sales	$	5,147,682	$	5,696,004	$	—	$	10,843,686
Cost of Goods Sold	$	4,134,884	$	4,299,108	$	—	$	8,433,992
Research and development	$	—	$	180,293	$	—	$	180,293
Stock based compensation	$	57,820	$	34,188	$	102,672	$	194,680
Selling, General and Administrative expenses, less stock based compensation	$	1,206,113	$	2,988,000	$	533,326	$	4,727,439
Income Statement for the three months ended June 30, 2022:
Net Sales	$	4,169,112	$	1,738,534	$	—	$	5,907,646
Cost of Goods Sold	$	3,695,267	$	908,587	$	—	$	4,603,854
Research and development	$	—	$	82,049	$	—	$	82,049
Stock based compensation	$	30,149	$	37,800	$	44,502	$	112,451
Selling, General and Administrative Expenses, less stock based compensation	$	1,195,460	$	2,033,074	$	690,230	$	3,918,764
Income Statement for the six months ended June 30, 2023:
Net Sales	$	11,229,055	$	10,269,114	$	—	$	21,498,169
Cost of Goods Sold	$	9,441,070	$	7,725,019	$	—	$	17,166,089
Research and development	$	—	$	369,503	$	—	$	369,503
Stock based compensation	$	114,674	$	70,364	$	199,771	$	384,809
Selling, General and Administrative Expenses, less stock based compensation	$	2,239,702	$	5,871,973	$	1,690,014	$	9,801,689
Income Statement for the six months ended June 30, 2022:
Net Sales	$	5,578,362	$	3,685,374	$	—	$	9,263,736
Cost of Goods Sold	$	4,853,911	$	1,956,934	$	—	$	6,810,845
Research and development	$	—	$	141,363	$	—	$	141,363
Stock based compensation	$	116,160	$	60,086	$	224,204	$	400,450
Selling, General and Administrative Expenses, less stock based compensation	$	1,854,548	$	3,818,284	$	1,059,159	$	6,731,991
Loss on impairment of goodwill	$	—	$	1,138,203	$	—	$	1,138,203